Tech Company Financing Transactions
VisiRose Funding Round
Private investors participated in a $3 million Seed capital raise for VisiRose. This VC investment round was announced on 1/16/2025.
Transaction Overview
Company Name
Announced On
1/16/2025
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to support new initiatives, including: Completing a pre-investigational new drug (IND) submission meeting with the U.S. Food and Drug Administration (FDA) for its Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a non-invasive, investigational treatment for infectious keratitis and other serious eye infections. Submitting an IND application for investigational drug PV-305, targeting corneal blindness (RB) through photodynamic therapy (PDAT), and working toward its acceptance by the FDA. Manufacturing an initial clinical supply of PV-305, enabling the company to initiate clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Knoxville, TN Undisclosed
USA
Knoxville, TN Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
VisiRose, a Knoxville, TN-based clinical-stage biotechnology company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dominic Rodrigues
Browse more venture capital transactions:
Prev: 1/16/2025: CH4 Global venture capital transaction
Next: 1/16/2025: Adaptive Reader venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs